As shown in the Kaplan–Meier survival curves, patients with GC and high ZSCAN18 methylation had significantly shorter survival times compared with those with GC who had low ZSCAN18 methylation (Fig. 1J). This evidence concerns the gene ZSCAN18 and gastric cancer.